Search Results - "Hruby G"

Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence.

Authors: Butow, P. Kelly, S. Thewes, B. et al.

Source: Psycho-Oncology. Apr2015, Vol. 24 Issue 4, p416-423. 8p. 5 Charts.

Subjects: Cancer relapse, Fear of diseases, Metacognition, Cancer patient psychology, Prostate cancer patients, Breast cancer patients

Management preferences following radical inguinal orchidectomy for Stage I testicular seminoma in Australasia.

Authors: Hruby, G Choo, R Jackson, M et al.

Source: Australasian Radiology. Sep2002, Vol. 46 Issue 3, p280-284. 5p.

The role of serial transrectal ultrasonography in a ‘watchful waiting’ protocol for men with localized prostate cancer.

Authors: Hruby, G. Choo, R. Klotz, L. et al.

Source: BJU International. May2001, Vol. 87 Issue 7, p643-647. 5p. 1 Chart.

Malignant retroperitoneal paraganglioma: Case report and review of treatment options.

Authors: Hruby, G Hruby, George Lehman, Margot et al.

Source: Australasian Radiology. Nov2000, Vol. 44 Issue 4, p478-482. 5p.

Late Genitourinary Toxicity Outcomes in 300 Prostate Cancer Patients Treated With Dose-escalated Image-guided Intensity-modulated Radiotherapy.

Authors: Byrne, K. Hruby, G. Kneebone, A. et al.

Source: Clinical Oncology. Sep2017, Vol. 29 Issue 9, p617-625. 9p.

The important role of radiation treatment in the management of Merkel cell carcinoma.

Authors: Hruby, G. Scolyer, R.A. Thompson, J.F.

Source: British Journal of Dermatology. Nov2013, Vol. 169 Issue 5, p975-982. 8p.

NECK DISSECTION AND IPSILATERAL RADIOTHERAPY IN THE MANAGEMENT OF CERVICAL METASTATIC CARCINOMA FROM AN UNKNOWN PRIMARY.

Authors: Mcmahon, J. Hruby, G. O’Brien, C. J. et al.

Source: Australian & New Zealand Journal of Surgery. Apr2000, Vol. 70 Issue 4, p263. 6p. 1 Diagram, 3 Charts, 4 Graphs.

EP-1544 Focal Linac-based SBRT Re-treatment for local recurrence of Ca P following previous definitive RT.

Authors: Hruby, G. Kneebone, A. Eade, T. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS833-S833. 1p.

Subjects: Prostate, Posters

EP-1455 Post chemoradiotherapy FDG-PET parameters predict for recurrence in anal cancer: a prospective trial.

Authors: Jones, M. Hruby, G. Metser, U. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS789-S789. 1p.

Subjects: Anal cancer, Cancer relapse

EP-1454 Multi-parametric MRI as a biomarker in anal cancer: a prospective trial.

Authors: Jones, M. Hruby, G. Kumar, M. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS789-S789. 1p.

Subjects: Anal cancer

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer.

Authors: Mohan, Riche Kneebone, A. Eade, T. et al.

Source: Radiation Oncology. 8/1/2023, Vol. 18 Issue 1, p1-7. 7p.

SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late Toxicity.

Authors: Whalley, D. Hruby, G. Alfieri, F. et al.

Source: Clinical Oncology. Oct2016, Vol. 28 Issue 10, pe148-e154. 1p.

PO-188 PROSTATE HDR BRACHYTHERAPY CATHETER DISPLACEMENT BETWEEN PLANNING AND TREATMENT DELIVERY AT SYDNEY CANCER CENTRE

Authors: Whitaker, M. Hruby, G. Lovett, A. et al.

Source: Radiotherapy & Oncology. May2012 Supplement, Vol. 103 Issue s2, pS76-S76. 1p.

Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma

Authors: Sundaresan, P. Hruby, G. Hamilton, A. et al.

Source: Clinical Oncology. Nov2012, Vol. 24 Issue 9, pe131-e136. 0p.

An audit of analgesia requirements for high-dose-rate prostate brachytherapy.

Authors: Doyle CA Loadsman JA Hruby G et al.

Source: Anaesthesia & Intensive Care. Sep2008, Vol. 36 Issue 5, p707-709. 3p.

Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol.

Authors: Honeyball, F. Murali‐Ganesh, R. Hruby, G. et al.

Source: Internal Medicine Journal. Oct2015, Vol. 45 Issue 10, p1081-1084. 4p. 1 Chart, 1 Graph.

Review of 120 anal cancer patients.

Authors: Young, S. C. Solomon, M. J. Hruby, G. et al.

Source: Colorectal Disease. Nov2009, Vol. 11 Issue 9, p909-914. 6p. 1 Diagram, 2 Charts.

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.

Authors: Goldstein, D Spry, N Cummins, M M et al.

Source: British Journal of Cancer. 1/3/2012, Vol. 106 Issue 1, p61-69. 9p. 1 Diagram, 5 Charts, 3 Graphs.

Ductal Carcinoma of the Prostate: An Uncommon Entity With Atypical Behaviour.

Authors: Bergamin, S. Eade, T. Kneebone, A. et al.

Source: Clinical Oncology. Feb2019, Vol. 31 Issue 2, p108-114. 7p.

Implementing Simulation-Free Radiotherapy (SFRT) Rapid Access Palliation in Routine Care: A Propensity Score Weight-Adjusted Analysis of the SFRT-1000 Cohort.

Authors: Schuler, T. Roderick, S. Wong, S. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS27-S27. 1p.